NTLA
Intellia Therapeutics Inc.
$12.62
+$0.35(+2.89%)
48
Overall
60
Value
50
Tech
36
Quality
Market Cap
$1.50B
Volume
14.23M
52W Range
$5.90 - $28.25
Target Price
$33.46
EPS Estimates Overview
| Current Quarter | $-1.03 | Next Quarter | $-1.01 |
| Current Year | $-4.14 | Next Year | $-4.1 |
| QoQ Growth | +1.9% | YoY Growth | +1.0% |
| 3Y EPS CAGR | +0.0% | Target Price | $33.46 |
| Consensus | Buy | Upside | +165.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $12.62 | +2.9% | 14.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW